This proposal constitutes a renewal application to study the role of the HIV-1 Vpr gene product. The overall goal of the studies proposed here is to understand the interaction between the various functions of Vpr and how they contribute to the pathogenesis of HIV-1. The hypothesis to be addressed here is that Vpr plays a critical role for HIV-1 replication and pathogenesis. The HIV-1 Vpr gene product is a 96 amino acid protein, which is important for viral replication and likely to be critical for HIV-1 pathogenesis. Vpr is expressed following infection of cells and is also found packaged in virions. In 1995, at the beginning of the initial funding period of this grant, we were among the first to describe a novel phenotype of the Vpr protein whereby cells infected by HIV-1 expressing Vpr undergo arrest at the G2 phase of the cell cycle. We focused our efforts on further characterizing this unique function of the Vpr protein. We have shown that cell cycle arrest is a highly evolutionarily conserved property of Vpr. In addition, we found that cell cycle arrest induced by Vpr is followed by apoptosis of the arrested cells. Other investigators have reported that Vpr enhances virus production and is involved in cytokine regulation. During the past funding period we made the important observation that Vpr that is packaged into virions is capable of inducing both cell cycle arrest and apoptosis independent of subsequent events in the viral lifecycle. Recently, we made the observation that virion Vpr is critical for expression from unintegrated viral DNA. Thus, in combination these results indicate that Vpr plays an important role in HIV-1 pathogenesis through the immediate early upregulation of viral gene expression and longer term effects upon T-cell metabolism. During the previous funding periods we have generated a considerable amount of preliminary data about Vpr action, developed a number of unique assays for assessment of Vpr function, and developed reagents which will allow us to effectively carry forward further studies on the mechanism of Vpr action.
The specific aims are:
Aim 1) To further characterize cell cycle arrest and apoptosis mediated by Vpr.
Aim 2) To characterize the newly described process of Vpr mediated transactivation of unintegrated HIV-1 DNA.
Aim 3) To further characterize the role of Vpr in viral pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA070018-12
Application #
7074828
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
1995-07-18
Project End
2008-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
12
Fiscal Year
2006
Total Cost
$319,089
Indirect Cost
Name
University of California Los Angeles
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kamata, Masakazu; Susanto, Melisa T; Chen, Irvin S Y (2009) Enhanced transthyretin tetramer stability following expression of an amyloid disease transsuppressor variant in mammalian cells. J Gene Med 11:103-11
Arokium, Hubert; Kamata, Masakazu; Chen, Irvin (2009) Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. J Virol 83:11283-97
Kamata, Masakazu; Watanabe, Nobumoto; Nagaoka, Yoshiko et al. (2008) Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for CDC2. J Virol 82:5672-82
Poon, Betty; Chang, Michael A; Chen, Irvin S Y (2007) Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA. J Virol 81:10515-23
Kamata, Masakazu; Wu, Raymond P; An, Dong Sung et al. (2006) Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1 Vpr induced cell death. Biochem Biophys Res Commun 348:1101-6
Poon, Betty; Chen, Irvin S Y (2003) Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA. J Virol 77:3962-72
Yuan, Huidong; Xie, Yi-Ming; Chen, Irvin S Y (2003) Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis. J Virol 77:2063-70
Gaynor, E M; Chen, I S (2001) Analysis of apoptosis induced by HIV-1 Vpr and examination of the possible role of the hHR23A protein. Exp Cell Res 267:243-57
Stewart, S A; Poon, B; Song, J Y et al. (2000) Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J Virol 74:3105-11
Jowett, J B; Xie, Y M; Chen, I S (1999) The presence of human immunodeficiency virus type 1 Vpr correlates with a decrease in the frequency of mutations in a plasmid shuttle vector. J Virol 73:7132-7

Showing the most recent 10 out of 13 publications